Actively Recruiting
Using PET Scans and Laboratory Tests to Improve Risk Assessment and Treatment in Newly Diagnosed Multiple Myeloma Patients
Led by Universiteit Antwerpen · Updated on 2025-07-28
120
Participants Needed
4
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating newly diagnosed multiple myeloma patients who are undergoing standard of care treatment including induction chemotherapy, autologous stem cell transplant ASCT, and lenalidomide maintenance therapy. The study aims to improve prediction of progression free survival by combining two techniques to detect minimal residual disease MRD. It also seeks to better classify patients by risk factors for early relapse, potentially leading to more personalized treatments in the future. Participants receive a whole-body FDG PETLDCT scan and a bone marrow sample for whole exome sequencing before starting induction chemotherapy. Those achieving at least a very good partial response after induction and ASCT will have repeated scans and MRD testing before starting maintenance therapy, after one year, and after two years of maintenance. Patients not reaching this response will still have follow-up during maintenance but without repeated scans or MRD testing. If relapse occurs, an additional bone marrow sample will be taken. Throughout maintenance therapy, participants are followed at least every three months to monitor treatment response or relapse using routine lab tests. The study measures MRD with next generation flow cytometry and evaluates risk stratification using whole exome sequencing and radiomics. The total follow-up includes up to two years of maintenance therapy or until progression, death, or study end, with ongoing assessments to better understand disease status and patient outcomes.
CONDITIONS
Brief Title
Positron Emission Tomography With Innovative Laboratory Techniques for Improved Risk and Disease Assessment in Newly Diagnosed Multiple Myeloma Patients
Research Team
S
Sofie De Rechter
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here